2Bedikian A Y.Metastatic uveal melanomatherapy: current options. Internationalophthalmology[J].Clinics, 2006, 46:151-166.
3Egan K M, Seddon J M, Glynn R J, et al.Edidemiologic aspects of uveal melano-ma[J], Surv Ophthalmol, 1988, 32:239-251.
4Kirkwood J M, Strawderman M H, Ern-stoff M S, et al. Interferon alfa-2b adju-vant therapy of high-risk resected cuta-neous melanoma: the Eastern Coopera-tive Oncology Group Trial EST 1684 [J],Journal of clinical oncology, 1996, 14:7-17.
